Access cutting-edge type 1 diabetes treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Access type 1 diabetes specialists in Palo Alto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related type 1 diabetes treatment provided free
The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with oral Vitamin D supplementation, to preserve endogenous beta cell function and influence glycemic parameters in adolescent and adults recently diagnosed with T1D carrying the HLA DR3-DQ2 haplotype.
Sponsor: Diamyd Medical AB
Check if you qualify for this type 1 diabetes clinical trial in Palo Alto, CA
If you're searching for type 1 diabetes treatment options in Palo Alto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 1 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.